samedan logo

home > news > detailed info

PharmaMarketing Summit returns 12-13 May in Boston, MA

PharmaMarketing Summit

We are thrilled to announce that the PHARMAMARKETING SUMMIT returns this May 12-13 in Boston, MA, USA!

The summit brings leading pharmaceutical marketing executives and innovative suppliers and service providers together at an exquisite location the Encore Boston Harbor, Boston, MA, USA.

The Summit’s content is aligned with key pharma marketing challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.

The summit effectively unites experts in an exclusive networking environment providing the opportunity to pre-schedule one-on-one physical business meetings with key leading and forward-thinking executives.

Delegates that attended in the past:
  • Neurocrine Biosciences - VP – Marketing
  • Proteon Therapeutics Inc - Senior Vice President Marketing
  • Horizon Pharma – Director
  • Takeda Pharmaceuticals - Director of Marketing Capabilities
  • Teva Pharmaceuticals - Marketing Senior Director
  • Baxalta - Marketing Director
  • BioMarin - Executive Dir - North America Brand Management • Daiichi Sankyo Inc. - Executive Director - Thrombosis
  • Dermira Inc. - VP - Marketing & Market Access
  • Etc.

To find more information about the summit you can visit or contact directly Isidora Avraam at #MKTSummit
phone +357 22 849 341
email Encore Boston Harbour, Boston, MA
Print this page
Send to a friend
News and Press Releases

New WITec Website Goes Live

WITec GmbH, the principal innovator of Raman imaging microscopy, has a new virtual address under the roof of Oxford Instruments plc. A refreshed look, updated structure and consolidated resources are ready to greet visitors and announce the next era in the company’s history. All content has been migrated while the navigation concept has been improved to make browsing more intuitive and informative.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence and Post Translational Modifications of a Monoclonal Antibody


Monoclonal antibodies are an important class of biopharmaceuticals. They are expressed from living cells and therefore, are subject to complex biochemical pathways. Not all of these pathways are fully understood and many are known to be sensitive to subtle environmental changes during production. These changes may affect the final biopharmaceutical sequence, structure and post-translational modifications. This is in addition to any changes that may occur during subsequent purification. This means that the final product from one batch may be subtly different from another batch. Furthermore, each batch is a heterogeneous mix of similar molecules. Analysis of the degree of batch-tobatch variation, and batch heterogeneity, is therefore, very important to establish in order to be confident that the drug is safe and effective for medicinal use.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement